ClinicalTrials.Veeva

Menu

Investigation of Microbiome-Derived Metabolite Production in Response to a Mediterranean Diet (META)

L

Laval University

Status

Completed

Conditions

Food Habits

Treatments

Other: Mediterranean diet

Study type

Interventional

Funder types

Other

Identifiers

NCT03783260
2018-262

Details and patient eligibility

About

This project proposes to characterise the microbiome-derived metabolites produced upon ingestion of bioactive precursor-rich meals by healthy volunteers in order to investigate the relationship between gut microbiome composition and the nature of dietary metabolites production.

Full description

There is a large inter-individual variability in gut microbiome-derived metabolites production upon ingestion of similar meals. Since many of these microbiome-derived metabolites have enteric and systemic biological effects, these variabilities could in part account for the different responses to meals and diets.

This project thus aims to improve the understanding the relationship between gut microbiome composition and the nature of dietary metabolites produced from similar bioactive precursor-rich meals.

The investigators therefore propose to characterise the circulating microbiome-derived metabolite profiles in healthy individuals fed the same 2-day precursor-rich Mediterranean diet prior to and after a 2-week of habitual Canadian diet feeding.

Enrollment

21 patients

Sex

All

Ages

18 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Men and women aged between 18 and 35 years
  • Body mass index between 18.5 and 30 kg/m2
  • General good health
  • Computer and Internet access
  • Basic understanding of written French

Exclusion criteria

  • Intestinal pathologies including inflammatory bowel disease and gastrointestinal cancers
  • Pregnant and/or breast-feeding women
  • Alcohol consumption greater than 15 portions for men and 10 for women weekly
  • Active tobacco usage
  • Consumption of dietary supplements (e.g. multivitamins, omega-3, probiotics)
  • Completion of a course of antibiotics in the past 3 months
  • Regular use of anti-inflammatory drugs, or use in the past 3 months
  • Important weight change (+/- 5 kg) in the past 6 months
  • Allergies or food intolerances to ingredients present in trial diets

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

21 participants in 1 patient group

Single
Experimental group
Description:
All participating subjects will undergo two, 2-day Mediterranean diet feeding periods separated by a 14-day period of Canadian diet
Treatment:
Other: Mediterranean diet

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems